Neuranics Unleashes 24/7 Heart Monitoring Revolution at CES 2024 with a Wearable Magnetocardiography (MCG) Development Platform
Magnetic sensor specialist startup Neuranics has announced that it will launch a magnetic sensor development kit that will record the magnetic activity of the heart and wirelessly transfer this over Bluetooth for live 24/7 recording and analysis on a smartphone,…
Blood cancers: AOP Health presents new findings in patients with polycythemia vera to be presented at the American Society of Hematology (ASH) 65th Annual Meeting
AOP Orphan Pharmaceuticals GmbH (AOP Health) has announced the launch of Ropeginterferon alfa-2b in patients with low-risk polycythemia vera (PV). We presented the results of an analysis evaluating the impact of individually optimized dosing regimens on therapeutic efficacy. 1These new data demonstrate…
World-renowned cancer researchers from Spain and the United States join forces to address critical needs and challenges in women’s cancer research
Mary Kay Inc. is the world’s leading direct-selling skin care and color cosmetics brand1 . The company and its sponsored foundations, including the Mary Kay Ash Foundation in the United States, continue to fund various research programs and projects, provide grants to world-renowned scientists, and promote clinical trials.…
ReNAgade Therapeutics appoints Paul Perrault as director
ReNAgade Therapeutics, the company unlocking the limitless potential of RNA medicines, appoints Paul Perrault to its board of directors, effective December 5, 2023. I announced what I had done. Mr. Perrault most recently served as Chief Executive Officer of CSL and has…
Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
Merck, a leading science and technology company, today announced that its two Phase III EVOLUTION clinical trials (evolutionRMS 1 and evolutionRMS 2) investigating the efficacy and safety of evobrutinib did not meet their primary endpoints of reducing annualized relapse rates…
Donor Alliance Awards Westminster Driver License Office for Saving & Healing Lives
Registration as an organ and tissue donor is a crucial component to Donor Alliance’s mission of saving and healing lives in the region. In Colorado, nearly all organ and tissue donor registrations come through driver license offices. To recognize this important…
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over…
New State-of-the-Art Hybrid Operating Room Unveiled at MarinHealth Medical Center
Today, MarinHealth Medical Center unveiled its new hybrid operating room, a surgical suite that combines the best tools of a traditional operating setting with advanced imaging technology. It offers advanced technology to provide real-time images for guidance during complex cardiovascular and vascular…
Erlanger Behavioral Health Hospital Hosts Ceremony to Celebrate Expansion
Erlanger Behavioral Health Hospital today reinforced its strong commitment to the communities it serves by opening 48 new beds at a new satellite location. The hospital held a ribbon-cutting event at the additional location – located at 632 Morrison Springs…
Exscientia receives grant from Open Philanthropy to explore a new therapeutic approach for pandemic influenza
Exscientia plc (Nasdaq: EXAI) today announced that it has received a $2.3 million grant from Open Philanthropy, a multi-program philanthropic funder in the field of global health and well-being. Under this grant, Exscientia intends to use activation of the host response…
The Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students
The Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students The Chuck Lorre Family Foundation has pledged a total of $10 million to Children’s Hospital Los Angeles to support…
CG Oncology Receives Both FDA Fast Track and Breakthrough Therapy Designation for Cretostimogene Grenadenorepvec in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CG Oncology, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted both Fast Track Designation and Breakthrough Therapy Designation for cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin (BCG)-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ with or without…